malaria_record: 98

Data license: Public Domain (CDC) · Data source: CDC Travelers' Health (Yellow Fever & Malaria, by country)

This data as json

record_id country_id valid_from valid_to is_current source_id fetch_run_id payload_sha256 content_hash area_of_risk_html relative_risk_html chloroquine_resist_html species_html recommended_prophylaxis_html cdc_updated_date has_transmission is_endemic whole_country_endemic country_has_any_prophylaxis_area screening_class prophylaxis_drugs_json species_json chloroquine_resistant area_summary created_at
98 98 2026-06-03   1 1 1 8eab5796788447f748d742bc3ea9c689b7dd02e0761828d2fa9fd151f54f3515 1cfb840a9b6e128f850fa49727d44dade6c81de1da69612aa8bc840ea554bee8
  • All areas of the country <2,500 m (<8,200 ft) elevation east of the Andes, including the cities of Iquitos and Puerto Maldonado
  • Rare cases in Tumbes and Piura regions
  • No malaria transmission in the following areas: Lima Province; the cities of Arequipa, Ica, Moquegua, Nazca, Puno, or Tacna; the highland tourist areas (the city of Cusco, Machu Picchu, Lake Titicaca); along the central and southern Pacific Coast
  
  • Chloroquine
  • P. vivax (80%)
  • P. falciparum (20%)
  • Areas <2,500m (<8,200 ft) elevation east of the Andes (see map): Atovaquone-proguanil, doxycycline, mefloquine, tafenoquine2
  • All other areas with malaria transmission (see map): No chemoprophylaxis recommended (insect bite precautions and mosquito avoidance only)4
Updated April 23, 2025
 2025-04-23 1 1 0 1 partial ["atovaquone-proguanil", "doxycycline", "mefloquine", "tafenoquine"] ["P. falciparum", "P. vivax"] 1 2 risk area statement(s); 1 no-transmission exclusion(s) 2026-06-03T22:10:28Z

Links from other tables